About us
Evidence-based, data-driven,
action-ready.

Molecular Health is a leading provider of data-driven software technology and solutions. For more than 10 years we have been dedicated to building software solutions that leverage a unique symbiosis of human expertise, state-of-the-art data curation, and deep analytics.

Molecular Health is a leading provider of data-driven software technology and solutions. For more than 10 years we have been dedicated to building software solutions that leverage a unique symbiosis of human expertise, state-of-the-art data curation, and deep analytics.

​Our mission is to transform the world’s biomedical knowledge into actionable insights.

To that end, we:

Deliver usable results

A transparent, intuitive, and informative user experience is at the core of our solutions.

Promote innovation

Our solutions evolve to meet current healthcare research needs and recommendations.

Build on diversity

Our teams tackle challenges with diverse ideas, strengths, and backgrounds.

Our people:
our greatest asset

Partnering with Molecular Health means more than using our advanced solutions. Our talented team of experts supports you in your efforts to build and utilize knowledge.

Our highly skilled subject matter experts ensure that our solutions always provide clean, relevant, high-quality data. Our analytics experts engineer MH Guide CAS and the dedicated data-driven analyses for AI Pharma Solutions. Our analytical strategies are meticulously documented and easily traceable, offering customers reliable solutions and services.

Read about our work:

Our database experts work behind the scenes to vet, organize, structure, and connect the massive datasets that are wrangled, standardized, and integrated from numerous sources into Dataome. Concurrently, our professional biomedical data curators keep a finger on the state of biomedical knowledge – from real-world data, molecular findings, and genomic insights to recommendations from authorities and regulatory drug approvals. Their work ensures that our solutions remain highly reliable, current, relevant, and useful to those who use them. In fact, our curators highlight high-impact publications, which we share with customers in our newsletter.

Our Customer Success Team includes application specialists who ensure that our partners are able to use MH Guide CAS to its full potential, providing guidance and support as needed. ​ At Molecular Health we provide our customers with cutting-edge, evidence-based insights that help to exploit biomedical knowledge​. 

Do you want to join our team of experts?​ 

Our management team

Friedrich von Bohlen und Halbach, PhD
Chief Executive Officer

Friedrich von Bohlen und Halbach, PhD
Chief Executive Officer

Chief Executive Officer

Friedrich von Bohlen und Halbach is a co-founder of Molecular Health. He has over 25 years of entrepreneurial experience in the industry and serves as chairman or board member of several national and international biotech companies and organizations. He holds a diploma in biochemistry from the University Zurich and a PhD in neurobiology from the Swiss Federal Institute of Technology, Zurich.

Stephan Brock, PhD
Chief Technology Officer

Stephan Brock, PhD
Chief Technology Officer

Chief Technology Officer

Stephan Brock is co-founder of Molecular Health. He has extensive experience in bioinformatics, data integration analytics, artificial intelligence, text-data mining, and content management for the pharmaceutical industry. He has led large-scale projects developing bioinformatics solutions supporting the pharma R&D value chain and IT infrastructure for integrative clinical trial data management at cancer centers. He holds a PhD in biochemistry from the University of Bayreuth.

Burkard Piper
Member of the Executive Team

Burkard Piper
Member of the Executive Team

Member of the Executive Team

Matthias Kopf, PhD
SVP, Head of Business Unit Molecular Analysis Solutions

Matthias Kopf, PhD
SVP, Head of Business Unit Molecular Analysis Solutions

SVP, Head of Business Unit Molecular Analysis Solutions

Matthias Kopf took over leadership of the Business Unit Molecular Analysis Solutions in 2023 after serving as Head of Product Management for five years. In his role, he oversees product management, customer success, medical affairs, marketing, and sales activities. He has a background in molecular biology and bioinformatics, having obtained his PhD in bioinformatics from the University of Freiburg (Germany) in 2015.

Josef Hermanns, PhD
SVP, Head of Project Management

Josef Hermanns, PhD
SVP, Head of Project Management

SVP, Head of Project Management

Josef Hermanns has over two decades of experience in strategic growth planning for IT, project controlling, and bioinformatics development. At Molecular Health, he coordinates central and AI Pharma Service projects, manages resources and licenses in R&D, and oversees data curation and content management for Dataome. He has a PhD from the Ruhr University Bochum (Germany).

Niels Bojunga, PhD
SVP of Quality Management

Niels Bojunga, PhD
SVP of Quality Management

SVP of Quality Management

Niels Bojunga is a microbiologist by training with over 20 years of professional experience in the area of software quality. As Head of Quality Management at Molecular Health, he oversees the company’s quality management system and quality assurance and guides regulatory compliance and certifications. He is the Quality Management Representative of Molecular Health.

Thorsten Vogt
Head of Human Resources

Thorsten Vogt
Head of Human Resources

Head of Human Resources

Thorsten Vogt has led Human Resources at Molecular Health since 2015. During that time, he guided the strategic expansion of all company sites and fostered the integration of employees from over 30 different countries. He oversees all personnel affairs, leveraging expertise from over two decades of managerial experience at international software and industrial corporations.

Your contacts

Marc-Alexander Rauschendorf, PhD
Head of Medical Affairs & Marketing 

Marc-Alexander Rauschendorf, PhD
Head of Medical Affairs & Marketing 

Head of Medical Affairs & Marketing

Reach out to Marc with questions about clinical trials, medical collaborations, tumor board support and KOL management. He also oversees attendance at conferences, outreach, PR, and publications.

Reach out to Marc

Lenka Kyjacova, PhD
VP, Customer and Partner Success

Lenka Kyjacova, PhD
VP, Customer and Partner Success

VP, Customer and Partner Success

Lenka and her team help customers and partners implement MH’s molecular analysis solutions. She supervises global product support, partner training, and develops strategies to enhance adoption, satisfaction, and retention. 

Reach out to Lenka

Anthony Caruso
SVP, Client Services

Anthony Caruso
SVP, Client Services

SVP, Client Services

Reach out to Anthony

Melanie Baumhögger
Head of Finance 

Melanie Baumhögger
Head of Finance 

Head of Finance 

Melanie handles any finance-related questions, from invoicing and purchase orders to accounts payable, fiscal statements, value added tax, and accounting.

Reach out to Melanie

Biljana Blagojevic, PhD
Scientific Process & Project Manager AI Pharma Solutions 

Biljana Blagojevic, PhD
Scientific Process & Project Manager AI Pharma Solutions 

Scientific Process & Project Manager AI Pharma Solutions

Whether you’re seeking a first contact, have specific questions about a possible collaboration, or want quick support within your ongoing AI Pharma Service project, get in touch with Biljana.

Reach out to Biljana

Our Board of Directors

Prof. Christof Hettich, PhD
Chairman of the Board of Directors

Prof. Christof Hettich, PhD
Chairman of the Board of Directors

is the CEO of SRH Holding, a leading provider of education and health services in Germany. He is also a senior partner at Rittershaus Rechtsanwälte, a law firm focusing on future-oriented industries, and co-founder of dievini Hopp BioTech Holding & Co. KG, the largest German investment company for LifeSciences, Healthcare and Health IT. He holds a doctorate in law and has extensive experience in corporate governance and financing.

Mathias Hothum, PhD
Member of the Board of Directors

Mathias Hothum, PhD
Member of the Board of Directors

is the managing director of dievini Hopp Biotech holding GmbH & Co. KG. He is currently also the founder and owner of HMM Consulting and the managing director of MSL Investments, DH Holding Verwaltungs, and MH-LT-Investments GmbH. He serves as Chairman of the Board of Joimax GmbH and Geuder AG, and as board member of Apogenix AG, CureVac NV, Heidelberg Pharma AG, and Novaliq GmbH. He studied business administration at the University of Mannheim and holds a PhD from the University of Magdeburg, Germany.

Alexander O. Schuth, PhD
Member of the Board of Directors

Alexander O. Schuth, PhD
Member of the Board of Directors

is co-founder and Chief Operating and Financial Officer of Denali Therapeutics, a biotechnology company focused on developing therapies for neurodegenerative diseases. He has extensive experience in corporate development, portfolio management, and finance. Before joining Denali, he worked at Genentech and the investment banking group at Merrill Lynch. He holds an M.D. from Humboldt University in Berlin and an M.B.A. from the Wharton School of the University of Pennsylvania.

Invest in precision medicine research

Molecular Health is privately funded by dievini Hopp Biotech holding GmbH & Co. KG, which invests in innovative precision medicine research companies with a focus on oncology, neurology, infectious diseases, cell therapy, and improved drug formulation. They support companies in their global development and marketing, with a geographic focus on Germany and Europe.

Do you have additional questions about our solutions and services? We want to hear from you!

GDPR Cookie Consent with Real Cookie Banner